Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2608 to 2657 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"3-KETOACYL-COA THIOLASE, PEROXISOMAL PRECURSOR (EC 2.3.1.16) (BETA- KETOTHIOLASE) (ACETYL-COA ACYLTRANSFERASE) (PEROXISOMAL 3-OXOACYL- COA THIOLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.668547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.15431\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211947145\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACAA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ACETYL-COENZYME A SYNTHETASE, CYTOPLASMIC (EC 6.2.1.1) (ACETATE--COA LIGASE) (ACYL-ACTIVATING ENZYME) (ACETYL-COA SYNTHETASE) (ACS) (ACECS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.503361\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.37915\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21157178\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACSS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ACYL-COENZYME A OXIDASE 1, PEROXISOMAL (EC 1.3.3.6) (PALMITOYL-COA OXIDASE) (AOX). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.974934\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.61324\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2113339\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACOX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOPOISOMERASE (DNA) II BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0461407\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.218331\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211333709\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TOPBP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP SYNTHASE F CHAIN, MITOCHONDRIAL (EC 3.6.3.14). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0258274\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.122212\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.211332766\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP5J2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROBABLE ATP-DEPENDENT HELICASE DDX35 (DEAH-BOX PROTEIN 35). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
DHX35\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KYNURENINASE (EC 3.7.1.3) (L-KYNURENINE HYDROLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.397319\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.88014\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211324157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KYNU\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"EXPORTIN 1; EXPORTIN-1 (REQUIRED FOR CHROMOSOME REGION MAINTENANCE); EXPORTIN 1 (CRM1, YEAST, HOMOLOG); CRM1, YEAST, HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.159172\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.75356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.211226711\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
XPO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 3 (EC 2.7.1.-) (MAP KINASE KINASE 3) (MAPKK 3) (MAPK/ERK KINASE 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.127536\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.605166\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.210745481\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP2K3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (EC 2.7.1.-) (MAP KINASE KINASE 6) (MAPKK 6) (MAPK/ERK KINASE 6) (SAPKK3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.143053\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.679075\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.210658617\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAP2K6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CLEAVAGE STIMULATION FACTOR SUBUNIT 3; CLEAVAGE STIMULATION FACTOR, 3' PRE-RNA, SUBUNIT 3, 77KD. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.412171\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.95716\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.210596477\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSTF3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALCOHOL DEHYDROGENASE CLASS III CHI CHAIN (EC 1.1.1.1) (GLUTATHIONE- DEPENDENT FORMALDEHYDE DEHYDROGENASE) (EC 1.2.1.1) (FDH). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.478004\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.27081\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.210499337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ESTERASE D (EC 3.1.1.1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.025126\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.119364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.210498978\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ESD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO-GTPASE-ACTIVATING PROTEIN 7 (RHO-TYPE GTPASE-ACTIVATING PROTEIN 7) (DELETED IN LIVER CANCER 1 PROTEIN) (DLC-1) (HP PROTEIN) (STAR-RELATED LIPID TRANSFER PROTEIN 12) (STARD12) (START DOMAIN-CONTAINING PROTEIN 12). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0241725\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.115107\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.210000261\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE 12 (EC 2.7.1.37) (EXTRACELLULAR SIGNAL-REGULATED KINASE 6) (ERK-6) (ERK5) (STRESS-ACTIVATED PROTEIN KINASE-3) (MITOGEN-ACTIVATED PROTEIN KINASE P38 GAMMA) (MAP KINASE P38 GAMMA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0331306\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.157765\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999683\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPK11\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPHINGOSINE KINASE 1 (EC 2.7.1.-) (SK 1) (SPK 1). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0241785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.115136\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.209999479\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SPHK1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPHINGOSINE KINASE 2 (EC 2.7.1.-) (SK 2) (SPK 2). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SPHK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAR-RELATED LIPID TRANSFER PROTEIN 13 (STARD13) (START DOMAIN- CONTAINING PROTEIN 13) (46H23.2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0197176\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0938936\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STARD13\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3; MAPKAP KINASE 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.052697\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.250939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999243\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPKAPK3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UDP-N-ACETYLGLUCOSAMINE--DOLICHYL-PHOSPHATE N- ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE (EC 2.7.8.15) (GPT) (G1PT) (N-ACETYLGLUCOSAMINE-1-PHOSPHATE TRANSFERASE) (GLCNAC-1-P TRANSFERASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0686246\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.326785\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999235\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DPAGT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOGEN-ACTIVATED PROTEIN KINASE 14 (EC 2.7.1.37) (MITOGEN-ACTIVATED PROTEIN KINASE P38ALPHA) (MAP KINASE P38ALPHA) (CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG BINDING PROTEIN) (CSAID BINDING PROTEIN) (CSBP) (MAX-INTERACTING PROTEIN 2) (MAP KINASE MXI2) \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0434669\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.206986\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999227\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPK14\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAP KINASE-ACTIVATED PROTEIN KINASE 2 (EC 2.7.1.-) (MAPK-ACTIVATED PROTEIN KINASE 2) (MAPKAP KINASE 2) (MAPKAPK-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0673673\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.320798\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPKAPK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-2 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0142351\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0677865\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHRNA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-6 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0131531\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0626341\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999026\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHRNA6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-4 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0186658\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0888852\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209998965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHRNA4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAR-RELATED LIPID TRANSFER PROTEIN 8 (STARD8) (START DOMAIN- CONTAINING PROTEIN 8). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0189378\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0901805\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209998836\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STARD8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NITROGEN FIXATION CLUSTER-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.416438\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.98305\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209998739\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ISCU\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-3 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0132921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0632961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.20999872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHRNA3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSFORMING PROTEIN RHOC (H9). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0215869\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.102796\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209997471\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RHOC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYSTATHIONINE BETA-SYNTHASE (EC 4.2.1.22) (SERINE SULFHYDRASE) (BETA-THIONASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.262879\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.25182\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209997444\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CBS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSFORMING PROTEIN RHOA (H12). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0246707\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.117481\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.209997361\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
RHOA\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-MERCAPTOPYRUVATE SULFURTRANSFERASE (EC 2.8.1.2) (MST). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MPST\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
AARSD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THIOSULFATE SULFURTRANSFERASE (EC 2.8.1.1) (RHODANESE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0214512\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.10215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209997063\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TST\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDATE CYTIDYLYLTRANSFERASE 2 (EC 2.7.7.41) (CDP-DIGLYCERIDE SYNTHETASE 2) (CDP-DIGLYCERIDE PYROPHOSPHORYLASE 2) (CDP- DIACYLGLYCEROL SYNTHASE 2) (CDS 2) (CTP:PHOSPHATIDATE CYTIDYLYLTRANSFERASE 2) (CDP-DAG SYNTHASE 2) (CDP-DG SYNTHETASE 2). [Source\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.515928\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.45712\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209972651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CDS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBC1 DOMAIN FAMILY MEMBER 5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.115058\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.547991\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209963302\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBC1D5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBBY PROTEIN HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0898392\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.427882\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.20996256\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TUB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROTEIN KINASE C, ZETA TYPE (EC 2.7.1.37) (NPKC-ZETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0704817\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.335687\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962554\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKCZ\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING 29 (VESICLE PROTEIN SORTING 29) (HVPS29) (MDS007) (PEP11) (DC7/DC15). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.179287\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.8539\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962525\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS29\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBBY RELATED PROTEIN 1 (TUBBY-LIKE PROTEIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0696821\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.331879\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962366\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TULP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROTEIN KINASE C, IOTA TYPE (EC 2.7.1.37) (NPKC-IOTA) (ATYPICAL PROTEIN KINASE C-LAMDA/IOTA) (APKC-LAMBDA/IOTA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.086385\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.411431\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962302\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKCI\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PARTITIONING DEFECTIVE-6 HOMOLOG GAMMA (PAR-6 GAMMA) (PAR6D). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0503166\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.239646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962194\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PARD6G\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2650\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING 35 (VESICLE PROTEIN SORTING 35) (HVPS35) (MATERNAL-EMBRYONIC 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0319827\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.152326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962186\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS35\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBBY RELATED PROTEIN 3 (TUBBY-LIKE PROTEIN 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.069842\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.332641\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209962091\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TULP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUMB PROTEIN HOMOLOG (H-NUMB) (PROTEIN S171). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.130073\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.619508\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209961776\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUMB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUMB-LIKE PROTEIN (NUMB-R). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.584702\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209961656\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUMBL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0359383\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.171181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209943276\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCAMP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0366237\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.174446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209942905\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCAMP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0466014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.221972\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209942695\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCAMP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SOLUTE CARRIER FAMILY 13, MEMBER 3 (SODIUM-DEPENDENT HIGH-AFFINITY DICARBOXYLATE TRANSPORTER 2) (NA(+)/DICARBOXYLATE COTRANSPORTER 3) (NADC-3) (HNADC3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0395353\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.188319\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209937924\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC13A3\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/